Solar Pharma to amass Innovcare Lifesciences for $28.7 million
Solar Pharmaceutical Industries (Solar Pharma) on Saturday stated it can purchase 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million). The corporate stated the acquisition will assist strengthen its portfolio within the specialty and branded generics phase whereas supporting its long-term progress technique in each home and worldwide markets….